← All themes

Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

Gene Therapy

#	Name	Funds holding	Growth	Growth %	Fund value
126	126 BioRestorative Therapies BRTX $2.07M	18	+9	+100%	$1M
127	127 Burning Rock Biotech BNR $154M	17	+1	+6%	$14.7M
128	128 Genprex GNPX $1.91M	17	+2	+13%	$155K
129	129 FibroBiologics FBLG $6.73M	16	-1	-6%	$270K
130	130 Lunai Bioworks LNAI $4.05M	16	-11	-41%	$641K
131	131 Pluri PLUR $11.7M	16	+2	+14%	$55.3K
132	132 Creative Medical Technology CELZ $5.86M	15	+4	+36%	$541K
133	133 Estrella Immunopharma ESLA $13.8M	15	-1	-6%	$4.99M
134	134 Eterna Therapeutics ERNA $2.46M	9	-6	-40%	$236K
135	135 Genenta Science GNTA $31.8M	9	-2	-18%	$1.33M
136	SLBT 136 SL Science Holding Ltd SLBT $869M	9	+9	–	$2.78M
137	137 ALPS Group Inc ALPS $58.2M	8	+1	+14%	$308K
138	138 Franklin Genomic Advancements ETF HELX $29.4M	6	0	0%	$3.78M
139	139 DELISTED SANGAMO THERAPEUTICS INC SGMO	6	-106	-95%	$29K
140	140 NewcelX Ltd NCEL $15.1M	4	0	0%	$42.6K
141	ACHL 141 DELISTED Achilles Therapeutics ACHL	3	0	0%	$98.9K
142	142 CytoMed Therapeutics GDTC $10.3M	3	0	0%	$12.2K
143	143 DELISTED Arcellx ACLX	2	-238	-99%	$3.43M
144	ATHX 144 DELISTED Athersys, Inc. Common Stock ATHX	1	0	0%	–
145	145 DELISTED Carisma Therapeutics CARM	1	-2	-67%	$4
146	146 DELISTED CATALENT, INC. CTLT	1	0	0%	$63
147	147 DELISTED Generation Bio GBIO	1	-1	-50%	$0
148	148 Corgi Genomics & Precision Medicine ETF GNMX $1.64M	1	+1	–	$387K
149	149 DELISTED NeuBase Therapeutics, Inc. Common Stock NBSE	1	0	0%	–
150	150 DELISTED NKGen Biotech, Inc. Common Stock NKGN	1	0	0%	$165K